SCHEMBL302289

SCHEMBL302289

NCCNN1C(=O)CSC1=S

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.51
ALDH1A1 P00352 7/20 0.51
RECQL P46063 5/20 0.51
TDP1 Q9NUW8 3/20 0.51
POLB P06746 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALPL P05186 1/20 0.51
ALPI P09923 1/20 0.51
ALPG P10696 1/20 0.51
PLCG1 P19174 1/20 0.51
CASP6 P55212 1/20 0.51
GSK3A P49840 7/20 0.46
GSK3B P49841 7/20 0.46
KMT2A Q03164 8/20 0.42
MEN1 O00255 7/20 0.42
GAA P10253 10/20 0.40
THRB P10828 3/20 0.38
HTT P42858 2/20 0.35
LMNA P02545 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28604051 0.74 MAPT (0.50) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL28459177 0.71 GSK3A (0.42) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL23930054 0.71
SCHEMBL11985604 0.71
Hydrochloric Acid SCHEMBL7533652 0.69 GSK3A (0.56) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL28470735 0.67 MAPT (0.43) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL3794356 0.67 MEN1 (0.65) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL3062340 0.66 GSK3A (0.62) MAPTALDH1A1RECQLTDP1POLB
SCHEMBL6324088 0.66 MAPT (0.67) MAPTALDH1A1RECQLTDP1POLB
N-Acetylaminorhodanine SCHEMBL8000045 0.66 MAPT (0.73) MAPTALDH1A1RECQLTDP1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110229165-B Up-conversion fluorescent probe rhodamine derivative and application thereof 苏州科技大学 2020-11-06 CN claimed
CN-110229165-A Up-conversion fluorescence probe Rhodamine Derivatives and its application 苏州科技大学 2019-09-13 CN claimed
CN-109970751-B Double-site high-sensitivity pH fluorescent probe and synthesis and application thereof 济南大学 2021-03-02 CN disclosed
CN-110229165-B Up-conversion fluorescent probe rhodamine derivative and application thereof 苏州科技大学 2020-11-06 CN disclosed
CN-110229165-B Up-conversion fluorescent probe rhodamine derivative and application thereof 苏州科技大学 2020-11-06 CN disclosed
CN-110229165-A Up-conversion fluorescence probe Rhodamine Derivatives and its application 苏州科技大学 2019-09-13 CN disclosed
CN-108997364-A The binary channels rhodamine fluorescence probe and its preparation and application of detection mercury ion and iron ion 东华大学 2018-12-14 CN disclosed
CN-108191884-A A kind of synthetic method of more unit and fluorescence unit compound molecules and its application 湖北工业大学 2018-06-22 CN disclosed
EP-1499358-B1 PH-SENSITIVE POLYMER EVONIK ROEHM GMBH (DE) 2012-04-18 EP disclosed
US-20120014905-A1 CONUGATED PROTEINS AND PEPTIDES POLYTHERICS LIMITED (GB) 2012-01-19 US disclosed
EP-2403538-A1 CONJUGATED PROTEINS AND PEPTIDES Polytherics Limited (GB) 2012-01-11 EP disclosed
US-7098030-B2 Polyampholytes for delivering polyions to a cell MIRUS BIO CORPORATION (US) 2006-08-29 US disclosed
EP-1620560-A1 DELIVERY OF SIRNA TO CELLS USING POLYAMPHOLYTES Mirus Corporation (US) 2006-02-01 EP disclosed
US-20050037496-A1 Polyampholytes for delivering polyions to a cell Arrowhead Madison Inc. 2005-02-17 US disclosed
US-6794189-B2 DRUG DELIVERY; GENE THERAPY MIRUS BIO CORPORATION 2004-09-21 US disclosed
WO-2004076674-A1 DELIVERY OF SIRNA TO CELLS USING POLYAMPHOLYTES MIRUS CORPORATION (US) 2004-09-10 WO disclosed
US-20040162235-A1 Delivery of siRNA to cells using polyampholytes MILLIPORE CORPORATION 2004-08-19 US disclosed
US-20020164315-A1 Polyampholytes for delivering polyions to a cell Arrowhead Madison Inc. 2002-11-07 US disclosed
US-6383811-B2 FORMING A COMPLEX OF POLYAMPHOLYTE AND POLYION AND DELIVERING THE COMPLEX INTO A CELL; DRUG DELIVERY MIRUS CORPORATION 2002-05-07 US disclosed
US-20010024829-A1 Polyampholytes for delivering polyions to a cell Arrowhead Madison Inc. 2001-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120014905-A1 CONUGATED PROTEINS AND PEPTIDES C1QBP, CHP1, MAN2A1 MAPT 4381/4885ALDH1A1 4682/4885RECQL 2222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.